Glycine (GLY) is gaining importance in medical diagnoses
due to
its relationship with multiple physiological functions. Today, GLY
is exclusively analyzed using instrumentation centralized in clinical
labs, and a tangible point-of-care tool that gathers real-time data
from the patient for effective and fast evaluations is lacking. Relevant
clinical advances are expected as soon as the rapid provision of both
punctual and continuous measurements is possible. In that context,
this work presents a microneedle (MN)-based biosensor for intradermal
GLY detection in interstitial fluid (ISF). The MN tip is externally
tailored to detect GLY levels through the hydrogen peroxide formed
in its reaction with a quinoprotein-based GLY oxidase enzyme. The
analytical performance of the MN biosensor indicates a fast response
time (<7 s); acceptable reversibility, reproducibility, and stability;
as well as a wide linear range of response (25–600 μM)
that covers the physiological levels of GLY in ISF. The MN biosensor
conveniently exhibits high selectivity for GLY over other compounds
commonly found in ISF, and the response is not influenced by temperature,
pH, or skin insertions. Validated intradermal measurements of GLY
were obtained at the in vitro (with pieces of rat skin), ex vivo (on-body
tests of euthanized rats) and in vivo (on-body tests of anesthetized
rats) levels, demonstrating its ability to produce accurate physiological
data. The developed GLY MN biosensor is skin-wearable and provides
reliable, real-time intradermal GLY measurements in ISF by means of
a minimally invasive approach.